Drug Profile


Latest Information Update: 05 Apr 2016

Price : $50

At a glance

  • Originator Hibernaid
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Clinical Phase Unknown Progeria
  • Preclinical Hot flashes
  • Research Brain injuries

Most Recent Events

  • 05 Apr 2016 Preclinical trials in Hot flashes in USA (PO) before April 2016
  • 05 Apr 2016 Clinical trials in Progeria in USA (PO) before April 2016
  • 05 Apr 2016 Early research in Brain injuries in USA (PO) before April 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top